inside your eye and
pressure increases As pressure increases,
it can damage your optic
nerve (which connects
your eye to your brain) Over time, this
damage to the optic nerve can
lead to vision loss
This simulator shows you how elevated eye pressure may affect your vision over time
DURYSTA™ helps to lower eye pressure in patients with open angle glaucoma or high eye pressure (ocular hypertension)
DURYSTA™ is a tiny, dissolvable implant your eye doctor places in your eye
As DURYSTA™ dissolves, it automatically releases medicine to help reduce high pressure inside your eye
Just 1 DURYSTA™ implant works for several months
DURYSTA™ consistently delivers medicine to your eye to help reduce high eye pressure.
In clinical studies for DURYSTA™, eye pressure was reduced for 15 weeks.
The most common side effect involving the eyes reported in patients using DURYSTA™ was eye redness. Other common side effects reported were: feeling like something is in your eye, eye pain, being sensitive to light, a blood spot on the white of your eye, dry eye, eye irritation, increased eye pressure, a loss of cells on the inner layer of the cornea, blurry vision, inflammation of the iris, and headache.
Person pictured here is not an actual DURYSTA™ patient.
What to expect with DURYSTA™
Here's what people are saying about DURYSTA™
Person pictured here is not an actual DURYSTA™ patient.
Several months of eye pressure control
1 dissolvable implant
The first and only FDA-approved dissolvable ocular implant to reduce eye pressure in people with open angle glaucoma or high eye pressure (ocular hypertension)
Just 1 tiny DURYSTA™ implant reduced eye pressure for 15 weeks in clinical studies
As DURYSTA™ dissolves, it automatically releases medicine to help reduce high pressure inside your eye
DURYSTA™ may be right for you, too
Ask your eye doctor about DURYSTA™
Find out if DURYSTA™ is right for you.
Here are some things to think about before speaking to your eye doctor:
Is elevated eye pressure an issue?
Do you understand elevated eye pressure and the risks associated with it?
Do you have difficulty applying your eye drops every day? (Hard time using them, or forgetting?)
Ask your eye doctor if you're eligible to pay as little as $20 for a DURYSTA™ implant*
* $1000 maximum benefit per eye applies; patient out-of-pocket expense may vary. Offer not valid for patients enrolled in Medicare, Medicaid, a Medicare drug benefit plan, TRICARE, or other federal or state health programs (such as medical assistance programs). Other limitations may apply.
Download our brochure to learn more about DURYSTA™
If you’re an eye doctor currently using DURYSTA™, please consider registering with the Find-A-Doctor Directory at DURYSTAFindADoctor.com. This will help potential DURYSTA™ patients get in touch with your practice.
INDICATIONS AND USAGE AND IMPORTANT SAFETY INFORMATION
IMPORTANT SAFETY INFORMATION AND INDICATIONS AND USAGE
DURYSTA™ should not be used if:
- You have any infection or suspected infection in your eye or surrounding eye area
- You have corneal endothelial cell dystrophy, a condition in which the clear front layer of your eye (cornea) has lost its ability to work normally and can cause vision problems
- You have had a corneal transplant or cells transplanted to the inner layer of the cornea (endothelial cell transplant)
- The sack that surrounds the lens of your eye (posterior lens capsule) is missing or torn
- You are allergic to any of its ingredients
DURYSTA™ may cause side effects involving the cornea, including increased risk of loss of cells from the inner layer of the cornea. You should not receive DURYSTA™ more than once in each eye. DURYSTA™ should be used with caution if you have a limited reserve of the cells lining the inner layer of the cornea.
DURYSTA™ should be used with caution if you have narrow or obstructed iridocorneal angles (the space where the iris, the colored part of the eye, and cornea meet).
DURYSTA™ may cause swelling of the macula, the center spot of the retina (back of the eye). DURYSTA™ should be used with caution if your eye does not have a lens, if you have an artificial lens and a torn posterior lens capsule, or if you have any risk factors for swelling of the macula.
DURYSTA™ may cause inflammation inside the eye or make existing inflammation worse.
DURYSTA™ may cause increased brown coloring of the iris, which may be permanent.
Eye injections have been associated with infections in the eye. It is important that you contact your doctor right away if you think you might be experiencing any side effects, including eye redness, sensitivity to light, eye pain, or a change in vision, after an injection. Your doctor should monitor you following DURYSTA™ administration.
The most common side effect involving the eyes reported in patients using DURYSTA™ was eye redness. Other common side effects reported were: feeling like something is in your eye, eye pain, being sensitive to light, a blood spot on the white of your eye, dry eye, eye irritation, increased eye pressure, a loss of cells on the inner layer of the cornea, blurry vision, inflammation of the iris, and headache.
APPROVED USES
DURYSTA™ (bimatoprost implant) is a prescription medicine to reduce eye pressure (also called intraocular pressure, or IOP) in patients with open angle glaucoma or high eye pressure (ocular hypertension).
Please see full Prescribing Information.
© 2020 AbbVie. All rights reserved. DURYSTA™ and its design are trademarks of Allergan, Inc., an AbbVie company.
DUR134135-v2 11/20
